← Back to Clinical Trials
Recruiting NCT07511764

NCT07511764 Comparison of Laryngeal Mask Airway Versus Endotracheal Intubation in Pediatric Laparoscopic Inguinal Hernia Repair

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07511764
Status Recruiting
Phase
Sponsor Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Condition Inguinal Hernia Repair
Study Type INTERVENTIONAL
Enrollment 266 participants
Start Date 2025-12-01
Primary Completion 2026-08-15

Eligibility & Interventions

Sex All sexes
Min Age 1 Year
Max Age 10 Years
Study Type INTERVENTIONAL
Interventions
General Aneasthesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 266 participants in total. It began in 2025-12-01 with a primary completion date of 2026-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Inguinal hernia is one of the most common conditions requiring surgical intervention in childhood, with a reported lifetime prevalence of 1-4%. With the increasing use of minimally invasive techniques such as PIRS (Percutaneous Internal Ring Suturing) among laparoscopic surgical procedures, perioperative anesthesia and airway management have become a critical area of clinical decision-making. The traditional approach in pediatric laparoscopic surgery is endotracheal intubation (ETT). Although ETT provides reliable airway control, it carries certain disadvantages. In contrast, the laryngeal mask airway (LMA) is less invasive and is associated with faster recovery. Systematic reviews and meta-analyses conducted in recent years have shown that the LMA may be safe for ventilation in pediatric laparoscopy, reduces peak airway pressure, and shortens recovery time. No well-designed, multicenter study with an adequate sample size comparing the LMA and ETT in pediatric laparoscopic inguinal hernia surgery has yet been conducted. This gap limits evidence-based decision-making in a clinical setting that directly impacts practice. Therefore, the aim of this study is to compare LMA and ETT in pediatric laparoscopic inguinal hernia repair. In this regard, the study is unique and necessary from both clinical and academic perspectives for determining the optimal airway strategy in pediatric laparoscopy.

Eligibility Criteria

Inclusion Criteria: * being between 1 and 10 years of age, * having a planned laparoscopic inguinal hernia repair, * being classified as ASA I-II, * having given informed consent from the parent. Exclusion Criteria: * Obesity (body weight \>95th percentile), * symptomatic gastroesophageal reflux, * high risk of aspiration, * upper airway anomalies, * history of difficult intubation, * acute respiratory tract infection, * emergency surgical indication, * need for conversion from laparoscopy to open surgery, * presence of additional systemic risks such as immunodeficiency/malignancy.

Contact & Investigator

Central Contact

Fikret Salık, associate professor

✉ fikretsalik@gmail.com

📞 +905076214125

Frequently Asked Questions

Who can join the NCT07511764 clinical trial?

This trial is open to participants of all sexes, aged 1 Year or older, up to 10 Years, studying Inguinal Hernia Repair. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07511764 currently recruiting?

Yes, NCT07511764 is actively recruiting participants. Contact the research team at fikretsalik@gmail.com for enrollment information.

Where is the NCT07511764 trial being conducted?

This trial is being conducted at Diyarbakır, Turkey (Türkiye).

Who is sponsoring the NCT07511764 clinical trial?

NCT07511764 is sponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital. The trial plans to enroll 266 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology